The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis
Authors
Keywords
-
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 12, Issue 2, Pages 159-166
Publisher
Informa UK Limited
Online
2012-03-30
DOI
10.1586/erp.12.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
- (2011) François-Emery Cotté et al. BMC HEALTH SERVICES RESEARCH
- The Economics of Improving Medication Adherence in Osteoporosis: Validation and Application of a Simulation Model
- (2011) Amanda R. Patrick et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo Adherence, Clinical Outcomes, and Mortality in the Womenʼs Health Initiative Randomized Hormone Therapy Trials
- (2011) Jeffrey R. Curtis et al. MEDICAL CARE
- Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women
- (2011) V. Breuil et al. OSTEOPOROSIS INTERNATIONAL
- Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram: rejoinder to comments by Pluskiewicz and Drozdzowska
- (2011) S. K. Sandhu et al. OSTEOPOROSIS INTERNATIONAL
- Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA)
- (2011) E. Landfeldt et al. OSTEOPOROSIS INTERNATIONAL
- Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
- (2011) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
- (2011) Susan Ross et al. VALUE IN HEALTH
- The societal burden of poor persistence to treatment of osteoporosis in Sweden
- (2010) Erik Landfeldt et al. BONE
- Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications
- (2010) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
- (2010) Mickaël Hiligsmann et al. HEALTH POLICY
- Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors
- (2010) S. M. Cadarette et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
- (2010) B. Jönsson et al. OSTEOPOROSIS INTERNATIONAL
- Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence
- (2010) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Overcoming problems with adherence to osteoporosis medication
- (2010) Véronique Rabenda et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
- (2009) Ethel S. Siris et al. AMERICAN JOURNAL OF MEDICINE
- Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis
- (2009) François-Emery Cotté et al. CLINICAL THERAPEUTICS
- Effect of Adherence on Lifetime Fractures in Osteoporotic Women Treated With Daily and Weekly Bisphosphonates
- (2009) Mark D Danese et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass
- (2009) D. L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
- (2009) I. Imaz et al. OSTEOPOROSIS INTERNATIONAL
- Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis
- (2009) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature
- (2009) Maribel Salas et al. VALUE IN HEALTH
- Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper
- (2009) L. Breitscheidel et al. JOURNAL OF MEDICAL ECONOMICS
- Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates
- (2008) Arlene M Gallagher et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis
- (2008) François-Emery Cotté et al. MEDICAL DECISION MAKING
- Incorporating adherence into health economic modelling of osteoporosis
- (2008) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis
- (2008) Dirk Mueller et al. PHARMACOECONOMICS
- The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates
- (2008) S. Rietbrock et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
- (2008) Spencer B. Cherry et al. VALUE IN HEALTH
- The cost-effectiveness of alendronate in the management of osteoporosis
- (2007) John A. Kanis et al. BONE
- A model of the public health impact of improved treatment persistence in post-menopausal osteoporosis in France
- (2007) François-Emery Cotté et al. JOINT BONE SPINE
- Medication Compliance and Persistence: Terminology and Definitions
- (2007) Joyce A. Cramer et al. VALUE IN HEALTH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now